Patent · US Active

Monoclonal antibodies against BCMA

US10683369B2 · kind B2 · utility

4Cited by

10References

21Claims

0Family size

Assignee

ENGMAB SÀRL · CH

Inventors

Minh Diem Vu · Wollerau, CH
Klaus Strein · Hemsbach, DE
Oliver Ast · Bassersdorf, CH
Marina BACAC · Schlieren, CH
Camille DELON · Oberengstringen, CH
Lydia Jasmin Hanisch · Schlieren, CH
Anne Freimoser-Grundschober · Bellinzona, CH
Christian Klein · Iffeldorf, DE
Ekkehard Moessner · Kreuzlingen, CH
Samuel Moser · Rotkreuz, CH
Pablo Umana · Wollerau, CH
Tina WEINZIERL · Schlieren, CH

Key dates

Filing date	Aug 3, 2016
Grant date	Jun 16, 2020
Priority date	—
Expiry date	Apr 17, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/70
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to new antibodies against BCMA, their manufacture and use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.